亚太地区合约包装：市场占有率分析、产业趋势、统计数据和成长预测（2025-2030 年）

亚太合约包装市场预计在预测期内复合年增长率为 12%

主要亮点

• 亚太合约包装市场的成长主要受到製造公司偏好变化的影响，这些公司通常将包装业务委託给第三方公司。这是因为製造商越来越关注成本优化和核心业务。
• 合约包装有几个优点。首先，它降低了製造商的营运成本。透过将包装业务委託给合约包装公司，由于机械成本和人事费用较低，营运成本可降低7%至9%。
• 市场客户正在寻找中国联合包装的保税区。保税区包括广东省、浙江省、上海市、福田市等沿海地区。这些保税区拥有强大的贸易和港口网络，对中国製造的产品不征收关税，没有出口许可证问题，也没有供应商和客户追踪。营运保税仓库的主要供应商包括 GPA Global、Asiapack 和 Presence Asia Group。
• 由于药品消费的快速增加以及各製药业疫苗产量的增加，目前印度对合约包装的需求正在增加。印度血清研究所 (SII) 是最大的疫苗製造商之一，生产Astra Zeneca的 Covishield 和美国竞争对手 Novavax Inc. 开发的另一种配方。为了应对第二波 COVID-19 浪潮导致的疫苗产量增加，市场供应商将有更多机会推出灌装服务。还有俄罗斯和乌克兰之间的战争对整个包装生态系统的影响。
• 在全球各製药产业的重大发展和投资的推动下，澳洲的联合包装服务也出现了强劲成长。例如，PCI Pharma Services (PCI) 收购了澳洲的 Pharmaceutical Packaging Professionals (PPP)。我们满足该地区的商业性联合包装服务需求。
• 在当前情况下，製造商需要根据产量而定的变动成本结构。该数量可以从 100 公升少量到大量不等。然而，由于其总成本，最小订单包装可能会对合约包装商造成损失，并可能导致製造商需要更多时间来外包计划。

亚太合约包装市场趋势

医药产业将迎来显着成长

• 联合包装使供应商能够适应药品等动态市场的独特变化。生产线的灵活性使公司能够避免重新包装操作，减少营运成本，并减少成品库存。
• 在亚太地区，随着中药和西药的普及以及大量药品的生产，中国医药市场呈现出巨大的机会。基于同样的原因，中国已成为高速泡壳包装最重要的市场。
• 儘管原料药生产在中国很常见，但大多数 CMO 仅限于生产液体或固态剂型。预计该国领先的製药公司对初级、二级和三级联合包装服务的需求将会增加，包括泡壳包装、塑胶容器和标籤。
• 由于各製药业药品消费量的快速增加以及疫苗产量的增加，目前印度对合约包装的需求正在增加。此外，该国还被称为阿育吠陀、同类疗法疗法药物和护肤的最大生产国之一。
• 印度是世界第12大药品出口国。全球有200多个国家出口印度药品，其中美国是主要市场。印度是全球主要学名药供应国之一，学名药占全球出口量的20%。印度22财年和21财年的药品出口总额分别为246亿美元和244.4亿美元。去年6月，印度医药品出口总额为211908万美元。

二次包装是推动市场的因素之一

• 对物理保护、屏障保护、二级密封、法规遵循和安全的需求不断增长，导致二次包装的采用增加。标准二次包装包括瓦楞纸箱、瓦楞纸箱、纸板/塑胶板条箱、小型充气枕、气泡包装、散装填充物和标籤。
• 二次包装包含包装层次，因此二次包装是消费者首先看到的，其重要性极高。因此，业内企业可以将包装外包，让自己的产品更具吸引力，吸引顾客。因此，在预测期内促进了市场成长。
• 在全球范围内，二次委託对于只想专注于药物开发的製药公司发挥重要作用。在这种情况下，公司会以合约形式聘请包装公司。在专注于产品研发的同时，运送产品的业务可能会委託。
• 二次性包装通常是消费者与品牌的第一次互动，无论是在线上、商店或介于两者之间。产品类型与典型的包装类型相关联，以便可以在过道中识别产品。
• 在当前的包装市场场景中，由于电子商务和零售的兴起，二次包装外包变得越来越流行。这使我们能够承担大型计划，而无需额外的劳动力或机械。

亚太合约包装产业概况

亚太合约包装市场需要变得更有凝聚力。区域市场的发展和当地企业在外国直接投资中所占份额的增加是推动市场碎片化的主要因素。该市场运营的公司包括 Central Glass、MJS Packaging、Stamar Packaging、TricorBraun、Premier Packaging 和 Sharp Packaging Services。

• 2022 年 7 月 - 全球合约包装和临床供应服务提供者Sharp Corporation与在中国营运的公司 ClinsChain 合作，扩大其业务和能力。Sharp Corporation将与ClinsChain合作，帮助Sharp Corporation的製药和生物製药客户进入中国市场，并帮助中国创新者扩大其全球足迹。该公司为区域和国际临床试验提供临床供应服务。

其他好处：

• Excel 格式的市场预测 (ME) 表
• 3 个月分析师支持

目录

第一章简介

• 研究假设和市场定义
• 调查范围

第二章调查方法

第三章执行摘要

第四章市场洞察

• 市场概况
• 产业价值链分析
• 产业吸引力－波特五力分析
  • 供应商的议价能力
  • 消费者议价能力
  • 新进入者的威胁
  • 替代品的威胁
  • 业内竞争对手之间的对抗关係
• 产业政策

第五章市场动态

• 介绍
• 促进因素
  • 快速的技术进步
  • 零售连锁发展
• 抑制因素
  • 内部包装
• 机会
  • 製药业

第六章 市场细分

• 按服务
  • 初级包装
  • 二次包装
  • 三级包装
• 按行业分类
  • 饮料
  • 食品
  • 药品
  • 居家及织物护理
  • 美丽
  • 其他的
• 按国家/地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 其他的

第七章 竞争格局

• 公司简介
  • Berkeley Contract Packaging
  • Central Glass
  • Unicep
  • MJS Packaging
  • Stamar Packaging
  • TricorBraun
  • Premier Packaging
  • DHL
  • Sharp Packaging Services
  • Multipack

第八章投资分析

第九章 市场未来展望

The Asia Pacific Contract Packaging Market is expected to register a CAGR of 12% during the forecast period.

Key Highlights

• Asia-Pacific contract packaging market growth is mainly influenced by the changing manufacturing firms' preferences, who usually outsource packaging activities to third-party players. It is because manufacturers are increasingly focusing on cost optimization and their core business.
• Contract packaging provides several advantages. Firstly, it reduces the operational costs of the manufacturers. The operating costs can be reduced by 7% to 9% by outsourcing packaging activities to contract packagers due to the reduced costs of machines and lowered labor costs.
• The customers in the market look for bonded zones for co-packaging in China. Some bonded zones include coastal zones such as Guandong, Zhejiang, Shanghai, and Futian. They have robust trade and port networks, no Customs Duty for products made out of China, No Export Licensing Issues, and No Supplier-Client Tracking. Some significant vendors operating in bonded sones are GPA Global, Asiapack, and Presence Asia Group.
• India is currently witnessing an increase in demand for contract packaging due to the sudden surge in medication consumption and increased vaccine production from various pharmaceutical industries. The Serum Institute of India (SII), one of the largest vaccine producers, manufactures AstraZeneca's Covishield and another formulation developed by US rival Novavax Inc. It increases opportunities for vendors in the market to introduce filling services to cater to the increased vaccine production during the second COVID-19 wave. There is also an impact of the Russia-Ukraine war on the overall packaging ecosystem.
• Australia is also witnessing robust growth for co-packaging services, with significant developments and investments made by various pharmaceutical industries worldwide. For instance, PCI Pharma Services (PCI) acquired Australia-based Pharmaceutical Packaging Professionals (PPP), one of the leading packaging, storage, distribution, and trial manufacturing providers. It caters to the need for commercial co-packing services in the region.
• In the current scenario, manufacturers require a variable cost structure based on volume. This volume might differ from a small quantity ranging from 100 l to a large one. However, packaging a minimum order might result in a loss for contract packagers, owing to its total costs, which could lead to manufacturers needing more time to outsource their projects.

APAC Contract Packaging Market Trends

Pharmaceutical Sector is Observing Significant Growth

• Co-packaging allows vendors to adapt to variations specific to a dynamic market, like Pharmaceuticals. Production line flexibilities help companies prevent repackaging work, reduce working capital, and lower finished goods inventories.
• In the Asia-Pacific region, the Chinese Pharmaceutical market offers enormous opportunities as more and more people gain access to Traditional Chinese Medicine (TCM) and Western medicine, produced in huge volumes. For the same reason, China became the most significant market for high-speed blister packaging.
• While API manufacturing is typical in China, most of the country's CMOs are limited to manufacturing liquid or solid dosage formulations. It is expected to increase the demand for co-packaging services on primary, secondary, and tertiary levels, such as blister packaging, plastic containers, and labeling, among others, for major pharmaceutical companies in the country.
• India is currently witnessing an increase in demand for contract packaging due to the sudden surge in medication consumption and increased vaccine production from various pharmaceutical industries. In addition, the country is also known for being one of the largest producers of Ayurvedic and Homeopathic medicine and skincare.
• India is the world's No. 12 exporter of medical supplies. More than 200 nations worldwide receive Indian medications for export, with the US serving as the primary market. The country is the world's leading supplier of generic medicines, with 20% of global exports made up of generic drugs. In FY22 and FY21, Indian medication and pharmaceutical exports totaled USD 24.60 billion and USD 24.44 billion, respectively. In June last year, Indian pharmaceutical and medicine exports totaled USD 2,119.08 million.

Secondary Packaging is One of the Factor Driving the Market

• The increasing need for physical and barrier protection, secondary containment, adherence to regulations, and safety increased secondary packaging adoption. Standard secondary packaging includes cardboard cartons, cardboard boxes and cardboard/plastic crates, small inflatable air pillows, bubble wrap, loose-fill, and labels.
• As secondary packaging involves a packaging level within it, it is the secondary packaging that the consumer gets to see first, making it of prime importance. It is propelling the players in the industry to outsource the packaging that enables them to increase the product's attractiveness and henceforth attract customers. Thus, it boosts market growth over the forecast period.
• Globally, secondary contract packaging plays a vital role for pharmaceutical companies that want to focus solely on developing the drug. In such cases, the company employs packaging companies on a contract basis. It is likely to let them focus on the R&D of the product while the packaging duties of the product for transportation are outsourced.
• Secondary packs are often the first interaction with the brand consumers have, whether online, in-store, or at any point in between. Brands have associated themselves with a typical packaging type so that their products are identified on aisles.
• In the current packaging market scenario, outsourcing secondary packaging is becoming increasingly popular, owing to the rise of e-commerce and retailing. Thus, it aids manufacturers in undertaking large projects without needing extra workforce or machinery while also enabling the company to strengthen its distribution channels.

APAC Contract Packaging Industry Overview

The Asia Pacific Contract Packaging market needs to be more cohesive. Regional market development and increasing local players' shares in foreign direct investments are the major factors promoting the fragmented nature of the market. Some of the players operating in the market Central Glass, MJS Packaging, Stamar Packaging, TricorBraun, Premier Packaging, and Sharp Packaging Services are some of the players.

• July 2022 - Sharp, a global provider of contract packaging and clinical supply services, partnered with ClinsChain, a company with operations in China, to increase its presence and capabilities. To help Sharp's pharma and biopharma clients gain access to the Chinese market while also assisting Chinese innovators in expanding their global footprint, Sharp will work with ClinsChain. This company provides clinical supply services for regional and international clinical trials.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Assumptions and Market Definition
• 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET INSIGHTS

• 4.1 Market Overview
• 4.2 Industrial Value Chain Analysis
• 4.3 Industry Attractiveness - Porter's Five Forces Analysis
  • 4.3.1 Bargaining Power of Suppliers
  • 4.3.2 Bargaining Power of Consumers
  • 4.3.3 Threat from new entrants
  • 4.3.4 Threat of Substitute Products
  • 4.3.5 Competitive rivalry within the industry
• 4.4 Industry Policies

5 MARKET DYNAMICS

• 5.1 Introduction
• 5.2 Drivers
  • 5.2.1 Rapid Technology Advancements
  • 5.2.2 Development in the Retail Chain
• 5.3 Restraints
  • 5.3.1 In-house packaging
• 5.4 Opportunities
  • 5.4.1 Pharmaceutical Industry

6 MARKET SEGMENTATION

• 6.1 By Service
  • 6.1.1 Primary Packaging
  • 6.1.2 Secondary Packaging
  • 6.1.3 Tertiary Packaging
• 6.2 By Vertical
  • 6.2.1 Beverages
  • 6.2.2 Food
  • 6.2.3 Pharmaceuticals
  • 6.2.4 Home and Fabric Care
  • 6.2.5 Beauty Care
  • 6.2.6 Others

• 6.3 By Country
  • 6.3.1 China
  • 6.3.2 India
  • 6.3.3 Japan
  • 6.3.4 Australia
  • 6.3.5 Others

7 COMPETITIVE LANDSCAPE

• 7.1 Company Profiles
  • 7.1.1 Berkeley Contract Packaging
  • 7.1.2 Central Glass
  • 7.1.3 Unicep
  • 7.1.4 MJS Packaging
  • 7.1.5 Stamar Packaging
  • 7.1.6 TricorBraun
  • 7.1.7 Premier Packaging
  • 7.1.8 DHL
  • 7.1.9 Sharp Packaging Services
  • 7.1.10 Multipack

8 INVESTMENT ANALYSIS

9 FUTURE OUTLOOK OF THE MARKET